Public health strategies to combat opioid crisis in the United States

[1] Ali M, Henke R, Mutter R, O’Brien P, Cutler E, Mazer-Amirshahi M, Pines J. Family member opioid prescriptions and opioid use disorder. Addictive Behaviors. 2019; 95: 58-63. Search in Google Scholar

[2] Carnes N, Wright E, Norwood C. A qualitative analysis of prescribers’ and dispensers’ views on improving prescription drug monitoring programs. Social and Administrative Pharmacy. 2017; 13: 1167-1174. Search in Google Scholar

[3] Center for Disease Control and Prevention. [Internet]. 2016 [cited 2019 Apr 23]; Available from: www.cdc.gov/drugoverdose/index.html Search in Google Scholar

[4] Edmund Rose M. Are prescription opioids driving the opioid crisis? Assumptions vs facts. Pain Med. 2018 Apr; 19(4): 793-807. Search in Google Scholar

[5] Florence C, Luo F, Xu L, Zhou C. The economic burden of prescription opioid overdose, abuse, dependence in the United States, 2013. Med Care. 2016; 54(10): 901-906. Search in Google Scholar

[6] Gilson A, Fishman S, Wilsey B, Casamalhuapa C, Baxi H. Time series analysis of California’s prescription monitoring program: Impact on prescribing and multiple provider episodes. American Pain Society. 2012; 13(2): 103-111. Search in Google Scholar

[7] Kaye A, Atluri S, Sanapati J, Benyamin R, Hirsch J, Manchikanti L. Reframing the prevention strategies of the opioid crisis: Focusing on prescription opioids, fentanyl and heroin epidemic. 2018; 21: 309-326. Search in Google Scholar

[8] Kazatchkine M, Bém P, Dreifus R. Why doctors should support regulated markets in illicit drugs. BMJ. [Internet]. 2018 Sep. [cited 2019 Apr 23]; Available from: blogs.bmj.com/bmj/2018/09/24/doctors-support-regulated-marketsillicit-drugs/ Search in Google Scholar

[9] Kumar V, Agboola F, Synnott P, Segel C, Webb M, Ollendorf D, Banken R, Chapman R. Impact of abuse deterrent formulations of opioids in patients with chronic pain in the United States: A cost-effectiveness model. Value in Health. 2019: 416-422 Search in Google Scholar

[10] Lyden J, Binswanger I. The United States opioid epidemic. Elsevier. 2019. Search in Google Scholar

[11] Pardo B. Do more robust prescription drug monitoring programs reduce prescription opioid overdose? Addiction. 2016; 1773-1786. Search in Google Scholar

[12] Patrick S, Fry C, Jones T, Buntin M. Implementation of prescription drug monitoring programs associated with reduction in opioid-related death rates. Health Affairs. 2016; Search in Google Scholar

[13] Rutkow L, Turner L, Lucas E, Hwang C, Alexander G. Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access. Health Affairs. 2015; 3: 484-492. Search in Google Scholar

[14] Schiller E, Mechanic O. Opioid overdose. Stat Pearls. [Internet]. 2019 [cited 2019 Apr 23]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK470415/ Search in Google Scholar

[15] Solberg C, Brown R, Du Vivier D, Meyer J, Ramachandran B. The US opioid crisis: Current federal and state legal issues. Anasthesia & Analgesia. 2017 Nov; 125(5): 1675-1681. Search in Google Scholar

[16] Weisberg D, Becker W, Fiellin D, Stannard C. Prescription opioid misuse in the United States and the United Kingdom: Cautionary lessons. International Journal of Drug Policy. 2014 Nov; 25(6): 1124-1130. Search in Google Scholar